SCOPUS 정보 검색 플랫폼

AIDS

Volumn 20, Issue 17, 2006, Pages 2239-2240

Costing implications of recent treatment interruption studies [3]

(2) Gill, M John a Krentz, Hartmut B a

a UNIVERSITY OF CALGARY (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

CD4 LYMPHOCYTE COUNT; DISEASE COURSE; DRUG EXPOSURE; HEALTH CARE COST; HEALTH CARE SYSTEM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; INFORMATION PROCESSING; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COSTS AND COST ANALYSIS; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; WITHHOLDING TREATMENT;

EID: 33750601941 PISSN: 02699370 EISSN: None Source Type: Journal
DOI: 10.1097/01.aids.0000252057.02187.73 Document Type: Letter

Times cited : (1)

References (6)

1
- 2642709177
- Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
- Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338:853-860.
- (1998) N Engl J Med , vol.338 , pp. 853-860
- Palella, F.J.¹ Delaney, K.M.² Moorman, A.C.³ Loveless, M.O.⁴ Fuhrer, J.⁵ Satten, G.A.⁶

2
- 33745070786
- Episodic CD4-guided use of antiretroviral therapy is inferior to continuous therapy: Results from the SMART Study
- and the SMART Study Investigators Denver, CO, USA, 5-8 February [Abstract 106LB]
- El-Sadar W, Neaton J. and the SMART Study Investigators. Episodic CD4-guided use of antiretroviral therapy is inferior to continuous therapy: results from the SMART Study. In: 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA, 5-8 February 2006 [Abstract 106LB].
- (2006) 13th Conference on Retroviruses and Opportunistic Infections
- El-Sadar, W.¹ Neaton, J.²

3
- 33749380953
- The CD4-guided strategy arm stopped in a randomized structured treatment interruption trial in west-African adults: ANRS 1269 Trivacan Trial
- Denver, CO, USA, 5-8 February [Abstract 105LB]
- Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Gabillard D, et al. The CD4-guided strategy arm stopped in a randomized structured treatment interruption trial in west-African adults: ANRS 1269 Trivacan Trial. In: 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO, USA, 5-8 February 2006 [Abstract 105LB].
- (2006) 13th Conference on Retroviruses and Opportunistic Infections
- Danel, C.¹ Moh, R.² Minga, A.³ Anzian, A.⁴ Ba-Gomis, O.⁵ Gabillard, D.⁶

4
- 33645058159
- Distribution of health care expenditures for HIV-infected patients
- Chen RY, Accortt NA, Westfall AO, Musgavero MJ, Raper JL, Cloud GA, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis 2006; 42:1003-1010.
- (2006) Clin Infect Dis , vol.42 , pp. 1003-1010
- Chen, R.Y.¹ Accortt, N.A.² Westfall, A.O.³ Musgavero, M.J.⁴ Raper, J.L.⁵ Cloud, G.A.⁶

5
- 0041352971
- The changing direct costs of medical care for patients with HIV/AIDS
- Krentz HB, Auld MC, Gill MJ. The changing direct costs of medical care for patients with HIV/AIDS. Can Med Assoc J 2003; 169:106-110.
- (2003) Can Med Assoc J , vol.169 , pp. 106-110
- Krentz, H.B.¹ Auld, M.C.² Gill, M.J.³

6
- 22244475456
- Impact of practice changes on an antiretroviral budget in an HIV care program
- Krentz HB, Gill MJ. Impact of practice changes on an antiretroviral budget in an HIV care program. Dis Manage Health Outcomes 2005; 13:209-217.
- (2005) Dis Manage Health Outcomes , vol.13 , pp. 209-217
- Krentz, H.B.¹ Gill, M.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.